Adam K. Stern Transactions Report

On September 18, 2025, all outstanding shares of Series C and Series D-2 Preferred Stock held by AKS Family Partners L.P. were automatically converted into shares of DarioHealth Corp. Common Stock. This conversion, including accrued dividends, was accelerated due to the Second Amended and Restated Certificates of Designation. Specifically, 250 shares of Series C Preferred Stock converted into 11,760 shares of Common Stock at a price of $40.40 per share, and 100 shares of Series D-2 Preferred Stock converted into 8,435 shares of Common Stock at $16.60 per share. These amounts are reported on a post-split basis following an August 28, 2025, 20-for-1 reverse stock split. Additionally, on September 24, 2026, 28,000 shares of Common Stock were acquired with an exercise price of $0, with vesting on the second anniversary of the grant date. Following these transactions, the post-transaction shares owned by AKS Family Partners L.P. are 17,906 and 26,341 respectively, and 57,717 shares in total.